EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modification of the HIV-1 Fusion Inhibitor 2P23 via N-Glycosylation Sites Enhances Its Cell Membrane Level and Antiviral Activity

Sofiia E Borovikova iD, Anna V Tvorogova iD, Mikhail V Shepelev iD, Natalia A Kruglova iD

International Journal of Molecular Sciences · 29.10.2026 · 27 (21) · 9695

DOI: 10.3390/ijms27219695 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.10.2026. Verfasst von Sofiia E Borovikova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Genome Research, Institute of Gene Biology, Russian Academy of Sciences, 34/5 Vavilova Str., 119334 Moscow, Russia. Hauptthemen laut MEDLINE: HIV Fusion Inhibitors, HIV-1, Cell Membrane, HIV Envelope Protein gp41. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HIV (Human immunodeficiency virus) gene therapy represents a promising strategy to suppress viral replication and potentially achieve long-term control of infection. One of the effective strategies is based on the generation of the genetically modified virus-resistant T cells by expressing peptide inhibitors of viral fusion on the cell membrane. These peptides, such as MT-C34 and 2P23, are derived from HIV gp41 protein and inhibit HIV entry into modified cells. We previously demonstrated in cell-to-cell viral transmission experiments that the 2P23 peptide showed lower protective activity than the MT-C34 peptide. In this study, we hypothesized that the difference in protective activity may arise from the differential N-glycosylation of the peptides. To test this, the 2P23 sequence was modified by introducing the N-glycosylation site (NDT) at the N-, C-, or both termini. These modifications significantly enhanced the plasma membrane expression and protective activity of the 2P23 peptide, with the NDT-2P23-NDT variant being the most potent. The validity of this peptide engineering approach was confirmed with the highly similar HP23L peptide, demonstrating an increased cell membrane expression and antiviral potency of the modified variant. Experiments with the N-glycosylation inhibitor tunicamycin provide indirect evidence that this effect is glycosylation-dependent. These findings suggest that introducing N-glycosylation sites is a versatile approach to improve the potency of membrane-bound antiviral peptides for HIV gene therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV Fusion InhibitorsHIV-1Cell MembraneHIV Envelope Protein gp41Peptide FragmentsGlycosylationHumansVirus ReplicationVirus InternalizationHEK293 Cells

Stichwörter der Autor:innen

2P23 peptideHIV-1 fusion inhibitorsHIV-1 infectionMT-C34 peptideN-glycosylationgene therapy

Substanzen

HIV Fusion InhibitorsHIV Envelope Protein gp41Peptide Fragments

Autor:innen und Institutionen

  • Center for Genome Research, Institute of Gene Biology, Russian Academy of Sciences, 34/5 Vavilova Str., 119334 Moscow, Russia.

ORCID-Profile: Sofiia E Borovikova, Anna V Tvorogova, Mikhail V Shepelev, Natalia A Kruglova

Förderung

  • Russian Science Foundation

Zitieren

APA

Borovikova, S. E., Tvorogova, A. V., Shepelev, M. V., & Kruglova, N. A. (2026). Modification of the HIV-1 Fusion Inhibitor 2P23 via N-Glycosylation Sites Enhances Its Cell Membrane Level and Antiviral Activity. International Journal of Molecular Sciences, 27(21), 9695. https://doi.org/10.3390/ijms27219695

Vancouver

Borovikova SE, Tvorogova AV, Shepelev MV, Kruglova NA. Modification of the HIV-1 Fusion Inhibitor 2P23 via N-Glycosylation Sites Enhances Its Cell Membrane Level and Antiviral Activity. International Journal of Molecular Sciences. 2026;27(21):9695. doi:10.3390/ijms27219695

BibTeX
@article{Borovikova2026,
  author = {Borovikova, Sofiia E and Tvorogova, Anna V and Shepelev, Mikhail V and Kruglova, Natalia A},
  title = {Modification of the HIV-1 Fusion Inhibitor 2P23 via N-Glycosylation Sites Enhances Its Cell Membrane Level and Antiviral Activity},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {21},
  pages = {9695},
  doi = {10.3390/ijms27219695}
}
Kostenlos starten →